Evaluation of Electrophysiological Effects of Melatonin and Alpha Lipoic Acid in Rats with Streptozotocine Induced Diabetic Neuropathy

Abstract

Introduction: Neuropathy is a common complication of diabetes mellitus and is closely related to quality of life. There are many studies in which biological ingredients, such as alpha lipoic acid (ALA), that may inhibit or reduce the generation of diabetic neuropathy were investigated. Another biological agent that may reduce the generation of diabetic neuropathy is melatonin and there are a few studies that investigate the effects of melatonin on diabetic neuropathy. In this study we aimed to examine the effect of melatonin on experimentally induced diabetic neuropathy by comparing it with both ALA and control groups.

Methods: We included 24 male Wistar rats. Tibial motor nerve conduction and cortical tibial nerve somatosensory evoked potentials (SEP) studies were performed before and after diabetes mellitus (DM) for all rats. Rats were divided into 3 (ALA, melatonin and control) groups. After 2 weeks of treatment period, tibial motor nerve conduction and cortical tibial SEP studies were repeated.

Results: Our data showed that ALA significantly increased nerve conduction velocity and amplitude in rats with diabetic neuropathy (p=0,001; p=0,002). Also, melatonin significantly increased nerve conduction velocity and amplitude in rats with diabetic neuropathy (p=0.002; p=0.002). There was no significant difference between the electrophysiological effects of ALA and melatonin. Besides, neither ALA nor melatonin did significantly affect P1 and N1 latency values on cortical tibial nerve SEP studies.

Conclusion: Our study is the study in which both tibial nerve conduction and cortical tibial SEP studies were performed to compare effects of ALA and melatonin on experimental diabetic neuropathy. Lack of significant difference on cortical tibial SEP study would be attributed to the involvement of other central nervous system pathways which do not include ALA or melatonin in the pathogenesis. Results of ALA group are important by means of giving objective evidences for results of biochemical studies about the role of ALA in the pathogenesis of diabetic neuropathy. However, there is not enough information about the effect of melatonin in the pathogenesis of diabetic neuropathy. Consequently, results of our study may anticipate further biochemical and clinic studies which investigate the about the role of melatonin in diabetic neuropathy.

Key words

alpha lipoic acid - melatonin - diabetic neuropathy

• References

• 1 American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2011; 34: 62-69
• 2 Brooks-Worrell B, Palmer JP. Is Diabetes mellitus a continuous spectrum?. Clin Chem 2011; 57: 158-161
• 3 Picon AP, Ortega NR, Watari R et al. Classification of the severity of diabetic neuropathy: a new approach taking uncertainties into account using fuzzy logic. Clinics 2012; 67: 151-156
• 4 Jacob S, Henriksen EJ, Schiemann AL et al. Enhancement of glucose disposal in patients with type 2 diabetes by alphalipoic acid. Arzneimittelforschung 1995; 45: 872-874
• 5 Cameron NE, Cotter MA, Horrobin DH et al. Effects of alpha-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids. Diabetologia 1998; 41: 390-399
• 6 Vallianou N, Evangelopoulos A, Koutalas P. Alpha-lipoic Acid and diabetic neuropathy. Rev Diabet Stud 2009; 6: 230-236
• 7 Ford I, Cotter MA, Camteron NE et al. The effects of treatment with alpha-lipoic acid or evening primrose oil on vascular hemostatic and lipid risk factors, blood flow, and peripheral nerve conduction in the streptozotocindiabetic rat. Metabolism 2001; 50: 868-875
• 8 Zencirci SG, Bilgin MD, Yaraneri H. Electrophysiological and theoretical analysis of melatonin in peripheral nerve crush injury. J Neurosci Methods 2010; 191: 277-282
• 9 Shokouhi G, Tubbs RS, Shoja MM et al. Neuroprotective effects of high dose vs low döşe melatonin after blunt sciatic nerve injury. Childs Nerv Syst 2008; 24: 111-117
• 10 Negi G, Kumar A, Sharma S. Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF- Κb and Nrf2 cascades. J Pineal Res 2011; 50: 124-131
• 11 Negi G, Kumar A, Kaundal RK et al. Functional and biochemical evidence indicating beneficial effect of melatonin and nicotinamide alone and in combination in experimental diabetic neuropathy. Neuropharmacology 2010; 58: 585-592
• 12 Erdoğan C, Cenikli U, Değirmenci E et al. Effect of hyperglycemia on conduction parameters of tibial nerve's fibers to different muscles: A rat model. J Neurosci Rural Pract 2013; 4: 9-12
• 13 Öktem F, Ozguner F, Yilmaz HR et al. Melatonin reduces urinary excretion of N-acetyl –b-D glucosaminidase, albumin and renal oxidative markers in diabetic rats. Clin Exp Pharmacol Physiol 2006; 33: 95-101
• 14 Armagan A, Uz E, Yilmaz HR et al. Effects of melatonin on lipid peroxidation and antioxidant enzymes in streptozotocininduced diabetic rat testis. Asian J Androl 2006; 8: 595-600
• 15 Stevens MJ, Obrosova I, Cao X et al. Effects of DLalpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes 2000; 49: 1006-1015
• 16 Kanter M, Uysal H, Karaca T et al. Depression of glucose levels and partial restoration of pancreatic beta-cell damage by melatonin in streptozotocin-induced diabetic rats. Arch Toxicol 2006; 80: 362-369
• 17 Ropper AH, Samuels MA. Adams and Victor’s Principles of Neurology. Emre M. Çev. Ed 9. edition Ankara: Güneş Tıp Kitapevleri; 2011: 1277-1282
• 18 Bessels GJ, Smale S, Duis SE et al. The effect of gammalinolenic acid-alpha-lipoic acid on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats. J Neurol Sci 2001; 182: 99-106
• 19 Papanas N, Maltezos E. α-Lipoic acid, diabetic neuropathy, and Nathan’s prophecy. Angiology 2012; 63: 81-83
• 20 Nagamatsu M, Nickander KK, Schmelzer JD et al. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 1995; 18: 1160-1167
• 21 Skalska S, Kucera P, Goldenberg Z et al Neuropathy in a rat model of mild diabetes induced by multiple low doses of streptozotocin: effects of the antioxidant stobadine in comparison with a high-dose alpha-lipoic acid treatment. Gen Physiol Biophys 2010; 29: 50-58
• 22 Zangiabadi N, Asadi-Shekaari M, Sheibani V et al. Data fruiy extract is a neuroprotective agent in diabetic peripheral neuropathy in streptozotocin-induced diabetic rats: a multimodal analysis. Oxid Med Cell Longev 2011; 976948
• 23 Karabay G, Zağyapan R, Take G et al. Elektron Mikroskopik İncelenmesi. Uludağ Üniversitesi Tıp Fakültesi Dergisi 2006; 32: 77-81
• 24 Roberts C, Torgerson DJ. Understanding controlled trials: baseline imbalance in randomised controlled trials. BMJ 1999; 319: 185
• 25 Villar J, Carroli G. Methodological issues of randomized controlled trials for the evaluation of reproductive health interventions. Prev Med 1996; 25: 365-375
• 26 Senoz S, Kutukcu Y, Aydin A et al. A cetyl salicylic acid improves somatosensory evoked potentials in streptozotocin-diabetic rats. Diabetes Res Clin Pract 1999; 46: 191-196
• 27 Piriz J, Torres-Aleman I, Nunez A. Independent alterations in the central and peripheral somatosensory pathways in rat diabetic neuropathy. Neuroscience 2009; 160: 402-411
• 28 Uzun N, Uluduz D, Mikla S et al. Evaluation of asymptomatic central neuropathy in type 1 diabetes mellitus. Electromyogr Clin Neurophysiol 2006; 46: 131-137
• 29 Das T, Kundu S, Mazumdar AK et al. Studies on central nervous system function in diabetes mellitus. J Indian Med Assoc 2001; 99: 84-89
• 30 Blackmer AB, Feinstein JA. Management of Sleep Disorders in Children With Neurodevelopmental Disorders: A Review. Pharmacotherapy 2016; 36: 84-98
• 31 Anderson G, Maes M. Oxidative/nitrosative stress and immuno-inflammatory pathways in depression: treatment implications. Curr Pharm Des 2014; 20: 3812-3847
• 32 Sande PH, Dorfman D, Fernandez DC et al. Treatment with melatonin after onset of experimental uveitis attenuates ocular inflammation. Br J Pharmacol 2014; 171: 5696-5707